Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE)

Nifurtimox is recommended for the treatment of Chagas disease; however, long-term follow-up data are scarce. This prolonged follow-up phase of the prospective, historically controlled, CHICO clinical trial evaluated seronegative conversion in pediatric patients aged <18 years with Chagas disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Altcheh, Jaime, Sierra, Victor, Ramirez, Teresa, Pinto Rocha, Jimy José, Grossmann, Ulrike, Huang, Erya, Moscatelli, Guillermo, Ding, Olivia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112190/
https://www.ncbi.nlm.nih.gov/pubmed/36975790
http://dx.doi.org/10.1128/aac.01193-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112190/
https://www.ncbi.nlm.nih.gov/pubmed/36975790
http://dx.doi.org/10.1128/aac.01193-22

Ejemplares similares